Philadelphia-area life sciences news this week includes updates on research on how to use CAR T-cell therapy to help kidney transplant patients, breakthrough therapy designation request for a drug candidate, and a drug for relapsed […]
PASADENA, Calif.–(BUSINESS WIRE)—- $ATHN #ArtificialIntelligence–Heliogen Inc. today announced that it has completed its previously announced business combination with Athena Technology Acquisition Corp. Click to view original post
SAN DIEGO: SAN DIEGO, Dec. 30, 2021 /PRNewswire/ — Regen BioPharma, Inc. (PINK: RGBP) and (PINK: RGBPP): First of all I would like to wish all our shareholders a happy holiday season. It has been […]
PLEASANTON, Calif.: PLEASANTON, Calif., Dec. 30, 2021 /PRNewswire/ — Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that it has completed 60MM USD Series B+ financing led by MSA Capital, a […]
CAMBRIDGE, Mass.: CAMBRIDGE, Mass., Dec. 30, 2021 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the company has successfully completed its previously announced acquisition of Lengo Therapeutics and lead compound LNG-451, a potential […]
At 24, Pooja Ika is launching her own health insurer, becoming one of the youngest people to do so in Massachusetts. The company has so far raised $10 million in seed funding from friends and […]
REDWOOD CITY, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will participate in the upcoming 40th […]
WATERTOWN, Mass., Dec. 29, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that […]
CARLSBAD, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, announces that they will present at the H.C. Wainwright […]
The company aims to close the gap between the results of preclinical studies and what actually happens in a clinical setting. Click here to view original post. Click here to view original post
© 2022 Biotech Networks, LLC
